Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participants

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108117Source: DataRank Database

The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participants is a research paper published in Contemporary Clinical Trials (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.80)OA: greenTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (35)

Peiqing Qian ORCID,William Meador,Sharon Lynch,Ram Narayan ORCID,Aimee Borazanci

Live enrichment

PubMed:41135813 PMC:PMC12951411 OpenAlex:https://openalex.org/W4415452112

Patient-Centered Outcomes Research Institute

Grant: MS-1610-37115

National Multiple Sclerosis Society

Grant: R-1902-33620

NIBIB NIH HHS

Grant: R01 EB036013

FWCI

3.80

Citation Percentile

0.9%

Citation Trend

2026

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12951411/pdf/nihms-2135901.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1551714425003118?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1551714425003118?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12951411/

Fields of Study

Multiple Sclerosis Research StudiesAmyotrophic Lateral Sclerosis ResearchPolyomavirus and related diseases

MeSH Terms

AdolescentAdultDisability EvaluationFemaleHumansMaleMiddle AgedResearch DesignRandomized Controlled Trials as TopicDisease ProgressionMultiple Sclerosis, Relapsing-RemittingYoung AdultPragmatic Clinical Trials as Topic

Keywords

Multiple sclerosisBaseline (sea)Multiple baseline designMEDLINEResearch designRandomized controlled trialDisabilityTherapeutic StrategyDisease-modifying Therapy

The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participants

FAIR Checklist

Authors (35)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)